Skip to content
Manuscript Formatter & Submission StudioCONSORT 2025 · SPIRIT 2025 · STROBE · PRISMA 2020 · TRIPOD+AI

Journal-Specific Manuscript Formatting & Preflight Validator

Open a Word, Markdown, or plain-text manuscript, or edit directly below. Select a journal to apply its available formatting rules and export an editable Word document.

Main Text Words265 / 3,000
Abstract Words138 / 250
Tables & Figures2 / 6
References2 / 50
Preflight Status1 Blocker · 1 Warn

Source Manuscript Draft

Non-Modification Guarantee: This studio never silently rewrites your statistical values, citations, or clinical conclusions. All missing venue sections are inserted with explicit `[Author Action Required]` markers.

FORMATTED FOR: RADIOLOGY: ARTIFICIAL INTELLIGENCE (ORIGINAL RESEARCH)Official Author Instructions ↗

Association of Early Point-of-Care Echocardiography With 30-Day Mortality in Septic Shock: A Multicenter Retrospective Cohort Study

Elena Rostova, MD; Marcus Vance, PhD; Priya Nair, MD, MPH

Division of Pulmonary and Critical Care Medicine, Academic Medical Center, Houston, TX, USA

Radiology: Artificial Intelligence Structured Abstract (4 parts)

138 / 250 words

Background: Early hemodynamic phenotyping in septic shock remains variable across intensive care units.

Methods: We conducted a retrospective cohort study across 6 adult intensive care units using de-identified electronic health records (2021-2025). Propensity score overlap weighting adjusted for baseline SOFA score, lactate, age, comorbidities, and vasopressor dose.

Results: Among 4,280 eligible adult patients with septic shock, 1,640 (38.3%) received point-of-care echocardiography within 6 hours. In the overlap-weighted cohort, 30-day mortality was 21.4% (351/1,640) in the early echocardiography group versus 25.8% (681/2,640) in the standard care group (adjusted risk ratio 0.83; 95% CI, 0.74-0.93; P = .002).

Conclusions: Early point-of-care echocardiography within 6 hours of septic shock recognition was associated with lower 30-day mortality and earlier targeted inotropic adjustment.

Key Points

Required by JAMA Network (75–100 words max)
**Question:** [State the primary research question addressed by this study in one sentence.] **Findings:** [In this observational cohort / case-control (strobe) of N participants, state the primary outcome with exact numeric effect estimates.] **Meaning:** [State the calibrated clinical or policy implication without overclaiming.]

Introduction

Septic shock is characterized by distributive vasoplegia frequently complicated by septic cardiomyopathy and occult hypovolemia [1, 2]. While international guidelines recommend dynamic fluid responsiveness assessment, the clinical effect of early structured bedside echocardiography on patient-centered survival endpoints remains uncertain. Our primary objective was to estimate the association between early point-of-care echocardiography (performed within 6 hours of vasopressor initiation) and 30-day all-cause mortality in a multicenter ICU cohort.

Methods

We conducted a multicenter retrospective observational cohort study reported in accordance with the STROBE guidelines. The study protocol was approved by the Institutional Review Board (IRB Protocol #2025-0842) with a waiver of informed consent for de-identified retrospective EHR analysis.

Results

Of 5,112 screened ICU admissions, 4,280 met eligibility criteria (Figure 1). Baseline characteristics before and after propensity weighting are presented in Table 1. Early echocardiography was associated with lower 30-day mortality (adjusted HR 0.81; 95% CI 0.72-0.91) and higher vasopressor-free days at day 28 (median 19 [IQR 11-24] vs 16 [IQR 8-22] days).

Discussion

In this multicenter cohort of 4,280 adults with septic shock, early bedside echocardiography was associated with a 4.4% absolute reduction in 30-day mortality.

Declarations & Author Statements

- **Ethics Approval and Consent to Participate:** Detected in manuscript text (verify protocol number). - **Clinical Trial / Study Registration:** [Blocker: Insert prospective clinical trial registration ID (e.g., ClinicalTrials.gov NCT#)] - **Conflict of Interest Disclosures:** Detected in manuscript text. - **Funding / Support:** Detected in manuscript text. - **Data and Code Availability:** Detected in manuscript text. - **Reporting Guideline Adherence:** Prepared in accordance with STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) (https://www.equator-network.org/reporting-guidelines/strobe/). - **AI-Assisted Technology Disclosure (Radiology: Artificial Intelligence Policy):** Detected in manuscript text. (Authors must disclose the use of generative AI tools in the Methods or Acknowledgments. AI cannot be credited as an author; humans retain full accountability.)

References

1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287 2. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Med. 2021;47(11):1181-1247. doi:10.1007/s00134-021-06506-y